bay-44-4400 and Toxascariasis

bay-44-4400 has been researched along with Toxascariasis* in 1 studies

Trials

1 trial(s) available for bay-44-4400 and Toxascariasis

ArticleYear
Efficacy of emodepside plus praziquantel tablets (Profender tablets for dogs) against mature and immature infections with Toxocara canis and Toxascaris leonina in dogs.
    Parasitology research, 2009, Volume: 105 Suppl 1

    The efficacy of emodepside plus praziquantel tablets (Profender tablets for dogs) against mature adult, immature adult and larval stages of Toxocara canis and Toxascaris leonina was evaluated in ten randomised, blinded and placebo-controlled dose confirmation studies in naturally or experimentally infected dogs. The tablets were used at the proposed minimum dose of 1 mg emodepside and 5 mg praziquantel per kg body weight. Efficacy was calculated based on worm counts after necropsy. Five studies demonstrated >99% efficacy against mature adult, >92% efficacy against immature adult, >98% efficacy against L4 and >94% efficacy against L3 larval stages of T. canis. Another five studies demonstrated >99% efficacy against mature and immature adult and >95% efficacy against L4 larval stages of T. leonina. No side effects of the treatment were observed. Emodepside plus praziquantel tablets thus provide a comprehensive new treatment option for ascarid infections in the dog.

    Topics: Administration, Oral; Animals; Anthelmintics; Depsipeptides; Dog Diseases; Dogs; Double-Blind Method; Feces; Parasite Egg Count; Placebos; Praziquantel; Tablets; Toxascariasis; Toxascaris; Treatment Outcome

2009